Abstract:Immunoglobulin A vasculitis (IgAV; formerly Henoch Schonlein Purpura) is the most common form of childhood vasculitis. It can occur in any age and peaks around 4–6 years old. It demonstrates seasonal variation implicating a role for environmental triggers and geographical variation. The diagnosis is made clinically and 95% of patients will present with a rash, together with any from a triad of other systems—gastrointestinal, musculoskeletal, and renal. Most cases of IgAV in children have an excellent outcome. Treatment may be required during the acute phase for gastrointestinal involvement and renal involvement, termed IgAV nephritis (previously HSP nephritis), is the most serious long-term manifestation accounting for ~1–2% of all childhood end stage kidney disease (ESKD). It therefore requires a period of renal monitoring conducted for 6–12 months. Patients presenting with nephrotic and/or nephritic syndrome or whom develop significant persistent proteinuria should undergo a renal biopsy to evaluate the extent of renal inflammation and there are now international consensus guidelines that outline the indications for when to do this. At present there is no evidence to support the use of medications at the outset in all patients to prevent subsequent renal inflammation. Consensus management guidelines suggest using oral corticosteroids for milder disease, oral, or intravenous corticosteroids plus azathioprine or mycophenolate mofetil or intravenous cyclophosphamide for moderate disease and intravenous corticosteroids with cyclophosphamide for severe disease. Angiotensin system inhibitors act as adjunctive treatment for persisting proteinuria and frequently relapsing disease may necessitate the use of immunosuppressant agents. Renal outcomes in this disease have remained static over time and progress may be hindered due to many reasons, including the lack of reliable disease biomarkers and an absence of core outcome measures allowing for accurate comparison between studies. This review article summarizes the current evidence supporting the management of this condition highlighting recent findings and areas of unmet need. In order to improve the long term outcomes in this condition international research collaboration is urgently required.

Risk Factors for Renal Involvement in Childhood Henoch-Schonlein Purpura (IgA Vasculitis)

IgA Vasculitis:A Review on Diagnosis and Management

Time of Onset and Risk Factors of Renal Involvement in Children with Henoch-Schönlein Purpura: Retrospective Study

The Laboratory Differential Diagnosis of Henoch-Schonlein Purpura

Clinical characteristics and risk factors for kidney involvement in children with immunoglobulin A vasculitis

Risk factors associated with IgA vasculitis with nephritis (Henoch–Schönlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis

Relationship between immune parameters and organ involvement in children with Henoch-Schonlein purpura

Henoch-Schönlein purpura with joint involvement: Analysis of 71 cases

Risk factors associated with renal crescentic formation in pediatric Henoch–Schönlein purpura nephritis: a retrospective cohort study

Childhood IgA Vasculitis (Henoch Schonlein Purpura)—Advances and Knowledge Gaps

Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review

[Clinical characteristics of Henoch-Schönlein purpura in children]

Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children

Pathogenesis of IgA Vasculitis: An Up-To-Date Review

Age of onset as a risk factor of renal involvement in Henoch-Schönlein purpura

Risk assessment and prediction model of renal damage in childhood immunoglobulin A vasculitis

Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schönlein purpura nephritis

Henoch-Schonlein Purpura Nephritis in Children: Incidence, Pathogenesis and Management

Atypical purpura and other features associated with unfavorable outcomes of IgA vasculitis (Henoch-Schönlein purpura) in children: A retrospective study

Urinalysis monitoring in children with Henoch-Schönlein purpura: Is it time to revise?

Effect of Nonimmune Factors on Renal Prognosis in Adult IgA Vasculitis With Nephritis: A Long-Term Retrospective Cohort Study